Next Oncology is a clinical research site located in San Antonio, Texas, United States 78229-6028.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Next Oncology has participated in 31 clinical trials with 16 currently active.
Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumor, Solid Tumor, Adult.
Sponsors: BeiGene, Shanghai Kechow Pharma, Inc., Valerio Therapeutics.
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Next Oncology has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Next Oncology has 31 clinical trials on record, with 16 currently active. Their work covers Advanced Solid Tumor, Metastatic Solid Tumor, Solid Tumor, Adult.
Yes — Next Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.